{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:42Z","timestamp":1760188422873},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1988,9,1]],"date-time":"1988-09-01T00:00:00Z","timestamp":589075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1988,9,1]],"date-time":"1988-09-01T00:00:00Z","timestamp":589075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1988,9]]},"DOI":"10.1007\/bf00175405","type":"journal-article","created":{"date-parts":[[2004,8,22]],"date-time":"2004-08-22T03:25:11Z","timestamp":1093145111000},"page":"231-237","source":"Crossref","is-referenced-by-count":4,"title":["Cisplatin, VP-16-213 and MGBG (Methylglyoxal bis guanylhydrazone) combination chemotherapy in refractory lymphoma, a phase II study"],"prefix":"10.1007","volume":"6","author":[{"given":"Lyubica","family":"Dabich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia K.","family":"Liepman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00175405_CR1","first-page":"1605","volume":"63","author":"AH Rossof","year":"1979","unstructured":"Rossof AH, Coltman Jr CA, Jones SE, Talley RW: Phase II Evaluation of Cis-Dichlorodiammineplatinum (II) in Lymphomas: A Southwest Oncology Group Study. Cancer Treat Rep 63:1605\u201308, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00175405_CR2","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/1097-0142(19811101)48:9<1927::AID-CNCR2820480902>3.0.CO;2-#","volume":"48","author":"F Cavalli","year":"1981","unstructured":"Cavalli F, Junghi WF, Nissen NI, Pajak TF, Coleman M, Holland JF: Phase II Trial of Cis-Dichlorodiammineplatinum (II) in Advanced Malignant Lymphoma. A Study of the Cancer and Acute Leukemia Group B. Cancer 48: 1927\u201330, 1981","journal-title":"Cancer"},{"key":"BF00175405_CR3","first-page":"258","volume":"14","author":"IR Judson","year":"1981","unstructured":"Judson IR, Wiltshaw E: Cis-Dichlorodiammineplatinum (Cis-Platinum) and Etoposide (VP-16) in Malignant Lymphoma \u2014 an Effective Salvage Regimen. Cancer Chemother Pharmacol 14:258\u201361, 1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00175405_CR4","first-page":"203","volume":"4","author":"RS Kaplan","year":"1985","unstructured":"Kaplan RS, Budman D, Gottlieb A, Anderson J: Phase II Trial of Etoposide (VP-16) and Cisplatin (DDP) in Refractory Non-Hodgkin's Lymphomas (NHL). A CALGB Study. Proc Am Soc Clin Oncol 4: 203, 1985 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Supple A","key":"BF00175405_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0305-7372(82)80076-5","volume":"9","author":"T Kroner","year":"1982","unstructured":"Kroner T, Obrecht JP, Junghi WF: Etoposide as Single Agent and in Combination with Cis-Platinum for Malignant Lymphomas. Cancer Treat Rev 9 (Supple A) 39\u201343, 1982","journal-title":"Cancer Treat Rev"},{"issue":"Supple A","key":"BF00175405_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0305-7372(82)80077-7","volume":"9","author":"HW Von Heyden","year":"1982","unstructured":"Von Heyden HW, Scherpe A, Nagel GA: Cis-Dichlorodiammineplatinum (II) (Cis-Platinum) and Etoposide for Patients with Refractory Lymphomas. Cancer Treat Rev 9 (Supple A) 45\u201352, 1982","journal-title":"Cancer Treat Rev"},{"key":"BF00175405_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/030089168206800611","volume":"68","author":"VP Fosser","year":"1982","unstructured":"Fosser VP, Salvagno L, Segati R, Pappagallo GL, Ferrazzi E, Sileni VC, Fiorentino MV: Cis-Dichlorodiammineplatinum (II), VP16\u2013213 and Prednisone (DVP Regimen) in the Treatment of Pretreated Advanced Malignant Lymphomas. Tumori 68:515\u20138, 1982","journal-title":"Tumori"},{"key":"BF00175405_CR8","first-page":"1033","volume":"70","author":"SF Williams","year":"1986","unstructured":"Williams SF, Ultman JE, Gaynor E, Watson S: Management of Advanced, Resistant Hodgkin's Disease and Non-Hodgkin's Lymphoma: A Phase II Study. Cancer Treat Rep 70:1033\u20134, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00175405_CR9","first-page":"246","volume":"3","author":"L Silverman","year":"1984","unstructured":"Silverman L, Jones R, Norton L, Cuttner J, Malamud S, Holland JF: Combination Chemotherapy for Refractory Lymphoma with Cytosine Arabinoside (A) Cisplatin (P) and Etoposide (E): APE. Proc Am Soc Clin Oncol 3:246, 1984 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00175405_CR10","first-page":"291","volume":"70","author":"BW Dana","year":"1986","unstructured":"Dana BW, Jones SE, Coltman C, Stuckey WJ: Salvage Treatment of Unfavorable Non-Hodgkin's Lymphoma with Cisplatin, Amsacrine, and Mitoguazone: A Southwest Group Pilot Study. Cancer Treat Rep 70:291\u20132, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00175405_CR11","first-page":"242","volume":"3","author":"F Camacho","year":"1984","unstructured":"Camacho F, Oken M, O'Connell M, Perri R, Phillips V, Wiernik P: Salvage Therapy in Patients (Pts) with Refractory Malignant Lymphoma Using Methylglyoxal Bisguanylhydrazone (MGBG), Vindesine (VDS) and Cisplatinum (CPPD). Proc Am Soc Clin Oncol 3:242, 1984 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00175405_CR12","first-page":"203","volume":"4","author":"A Tseng Jr","year":"1985","unstructured":"Tseng Jr A, Jacobs C, Coleman C, Horning S, Lewis B, Rosenberg S: Treatment of Refractory Non-Hodgkin's Lymphomas of Unfavorable Histology with Tenoposide (VM-26), Cytosine Arabinoside (Ara-C) and Cisplatin. Proc Am Soc Clin Oncol 4:203, 1985 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00175405_CR13","first-page":"237","volume":"3","author":"ASD Spiers","year":"1984","unstructured":"Spiers ASD, Weens JH, Parkinson DR, O'Connell MJ: Treatment of Refractory Lymphomas with BCNU, Bleomycin, VM-26, Dexamethasone and Cisplatin (BBVDD Regimen). Proc Am Soc Clin Oncol 3:237, 1984 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00175405_CR14","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/1097-0142(19821215)50:12<2736::AID-CNCR2820501207>3.0.CO;2-7","volume":"50","author":"MK Liepman","year":"1982","unstructured":"Liepman MK, Wheeler RH, Zuckerman KS, LoBuglio AF: Combination Chemotherapy of Refractory Lymphoma with Cis-Dichlorodiammineplatinum, Vinblastine and Bleomycin. Cancer 50:2736\u201339, 1982","journal-title":"Cancer"},{"key":"BF00175405_CR15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1097-0142(19840715)54:2<202::AID-CNCR2820540204>3.0.CO;2-I","volume":"54","author":"MP Corder","year":"1984","unstructured":"Corder MP, Clamon GH: Salvage Therapy of Aggressive Non-Hodgkin's Lymphoma with a Combination of Vinblastine, Bleomycin and Cisplatin. Cancer 54:202\u20136, 1984","journal-title":"Cancer"},{"key":"BF00175405_CR16","first-page":"191","volume":"5","author":"W Velasquez","year":"1986","unstructured":"Velasquez W, Caranillas F, McLaughlin P, Plunkett W, Hagemeister F, Swan F, Freireich EJ: Combination of Cisplatin-Ara-C and Decadron in Relapsing Lymphoma. Proc Am Soc Clin Oncol 5: 191, 1986 (Abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00175405_CR17","first-page":"1231","volume":"63","author":"PA Radice","year":"1979","unstructured":"Radice PA, Bunn Jr PA, Ihde DC: Therapeutic Trials with VP-16\u2013213 and VM 26: Active Agents in Small Cell Lung Cancer, Non-Hodgkin's Lymphoma and Other Malignancies. Cancer Treat Rep 63:1231\u201339, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00175405_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19800115)45:2<232::AID-CNCR2820450206>3.0.CO;2-F","volume":"45","author":"NI Nissen","year":"1980","unstructured":"Nissen NI, Pajak TF, Leone LA, Bloomfield CD, Kennedy BJ, Ellison RE, Silver RT, Weiss RB, Cuttner J, Falkson G, Kung F, Bergevin PR, Holland JF: Clinical Trial of VP\/16\u2013213 (NSC141540) I.V. Twice Weekly in Advanced Neoplastic Disease. A Study by the Cancer and Leukemia Group B. Cancer 45:232\u201335, 1980","journal-title":"Cancer"},{"key":"BF00175405_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0305-7372(79)80045-6","volume":"6","author":"BF Issel","year":"1979","unstructured":"Issel BF, Crooke ST: Etoposide (VP-16\u2013213). Cancer Treat Rev 6:107\u201324, 1979","journal-title":"Cancer Treat Rev"},{"key":"BF00175405_CR20","first-page":"183","volume":"16","author":"E Freireich","year":"1962","unstructured":"Freireich E, Frei III E, Karon M: Methylglyoxal Bis (guanylhydrazone): A New Active Agent Against Acute Myelocytic Leukemia. Cancer Chemother Rep 16:183\u201386, 1962","journal-title":"Cancer Chemother Rep"},{"key":"BF00175405_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.2830050305","volume":"5","author":"RA Bender","year":"1978","unstructured":"Bender RA, Anderson T, Fisher RI, Young RC: Activity of the Epipodophyllotoxin VP-16 in the Treatment of Combination Chemotherapy-Resistant Non-Hodgkin Lymphoma. Amer J Hematol 5:203\u201309, 1978","journal-title":"Amer J Hematol"},{"key":"BF00175405_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00208895","volume":"1","author":"WAT Knight III","year":"1983","unstructured":"Knight III WAT, Fabian C, Constanzi JJ, Jones SE, Coltman Jr CA: Methyl-glyoxal Bis Guanylhydrazone (Methyl-gag, MGBG) in Lymphoma and Hodgkin's Disease. Invest New Drugs 1:235\u20137, 1983","journal-title":"Invest New Drugs"},{"key":"BF00175405_CR23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V57.6.1011.1011","volume":"57","author":"RP Warrell","year":"1981","unstructured":"Warrell RP, Lee BJ, Kempin SJ, Lacher MJ, Straus DJ, Young CW: Effectiveness of Methyl-Gag (Methylglyoxal-Bis [Guanylhydrazone]) in Patients with Advanced Malignant Lymphoma. Blood 57:1011\u201314, 1981","journal-title":"Blood"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00175405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00175405\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00175405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00175405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:45:36Z","timestamp":1678556736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00175405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,9]]}},"alternative-id":["BF00175405"],"URL":"https:\/\/doi.org\/10.1007\/bf00175405","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,9]]}}}